Vilin Bio Med Financials

NSE: VILINBIO

₹57.85

₹-1.90 (-3.18%)

As on 09-Sep-2026IST

Market cap

₹88 Cr

Revenue (TTM)

₹42 Cr

P/E Ratio

45.7

P/B Ratio

3.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	42.26	14.81	15.80	12.31	11.21	11.72
Total Income	42.26	15.28	16.13	12.34	11.22	11.74
Total Expenditure	39.07	14.02	14.99	9.74	10.45	10.88
EBITDA	3.19	0.79	0.82	2.57	0.77	0.83
Depreciation	0.28	0.10	0.13	0.17	0.22	0.26
EBIT	2.91	0.68	0.69	2.41	0.55	0.58
Interest	0.07	0.85	0.79	0.65	0.51	0.44
Other Income	0.00	0.47	0.32	0.02	0.00	0.03
Exceptional Items	--	--	--	--	--	--
Profit before Tax	2.84	0.31	0.23	1.78	0.04	0.16
Provision for Tax	0.91	0.08	0.06	0.54	0.01	0.04
Profit after Tax	1.93	0.22	0.16	1.25	0.03	0.12

Liabilities (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	28.37	23.06	22.84	10.68	7.40	7.36
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.13	0.09	0.29	0.50	0.79	1.07
Current Liabilities	6.44	4.62	9.27	6.50	5.37	5.46
Total Liabilities	34.94	27.78	32.40	17.68	13.56	13.89

Assets (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	7.56	7.90	13.79	9.62	1.65	1.92
Current Assets	27.38	19.88	18.62	8.05	11.91	11.97
Total Assets	34.94	27.78	32.40	17.68	13.56	13.89
Total Debt*	0.21	2.57	6.83	4.93	5.30	5.52
Net Current Assets	20.94	15.26	9.34	1.56	6.54	6.52
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	0.70	0.21	-7.42	-1.66	0.21	-1.00
Cash Flow from Investing Activities	-0.30	-1.11	0.32	-0.03	--	--
Cash from Financing Activities	1.01	-5.10	8.87	1.68	-0.22	0.98
Net Cash Inflow / Outflow	1.41	-5.99	1.77	0.00	-0.01	-0.02

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	1.26	0.16	0.12	1.25	0.04	0.15
Cash EPS (₹)	1.45	0.24	0.21	1.42	0.31	0.46
Adjusted Book Value (₹)	18.60	16.53	16.37	10.73	8.97	8.92
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	0.46	0.15	-5.32	-1.67	0.63	-3.04
Free Cash Flow per Share (₹)	0.24	-1.25	-5.66	-1.70	0.63	-3.04

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	10.73	4.16	4.47	17.17	4.31	4.89
ROE (%)	7.50	0.97	0.97	13.78	0.46	1.66
ROA (%)	6.15	0.74	0.65	7.97	0.24	0.87
EBIT Margin (%)	6.88	4.61	4.34	19.54	4.87	4.93
Net Margin (%)	4.56	1.46	1.01	10.09	0.30	1.03
Cash Profit Margin (%)	5.24	2.21	1.85	11.47	2.25	3.23

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	185.37	-6.30	28.36	9.79	-4.27	-30.32
EBIT Growth (%)	326.15	-0.61	-71.45	340.16	-5.32	-1.77
Net Profit Growth (%)	762.66	37.68	-86.96	3,605.36	-72.30	-25.22
EPS Growth (%)	689.08	37.71	-90.70	2,974.45	-72.32	-25.22
Book Value Growth (%)	23.02	0.98	113.91	44.37	0.46	1.68

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	28.97	127.26	163.23	--	--	--
Price / Book Value	1.97	1.23	1.16	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	17.10	24.67	23.91	5.72	11.12	10.19
Close Price (₹)	36.65	20.40	19.00	--	--	--
High Price (₹)	38.40	27.70	30.45	--	--	--
Low Price (₹)	18.95	15.40	18.10	--	--	--
Market Cap (₹ Cr)	55.89	28.46	26.50	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.01	0.11	0.30	0.46	0.72	0.75
Short term debt to equity ratio	0.01	0.11	0.29	0.42	0.62	0.61
Current Ratio	4.25	4.30	2.01	1.24	2.22	2.19
Quick Ratio	3.13	3.35	1.53	1.10	1.79	1.82
Interest Coverage	42.29	1.36	1.29	3.75	1.09	1.36

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	37.75	57.77	35.96	45.48	69.43	65.26
Asset Turnover	1.35	0.49	0.63	0.79	0.82	0.84
Receivable days	105.84	175.47	130.30	198.42	251.12	232.34
Inventory Days	50.21	109.42	61.73	46.88	70.76	65.02
Payable days	23.25	45.95	44.10	46.59	30.01	54.06
Cash Conversion Cycle	132.80	238.93	147.94	198.71	291.87	243.30